FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Companies Worrying About Woodcocks Successor

[ Price : $8.95]

A Reuters report says drug industry executives are concerned about who will succeed Janet Woodcock when she retires.

Pfizer Psoriasis Drug Meets 2 Trial Primary Endpoints

[ Price : $8.95]

Pfizer says two Phase 3 trials of its psoriasis drug tofacitinib met most of their primary endpoints.

Alkermes Gains Fast Track for Depression Drug

[ Price : $8.95]

FDA grants Alkermes fast track status for ALKS 5461 for the adjunctive treatment of major depressive disorder.

Sotera Wireless Patients Monitoring Technology Cleared

[ Price : $8.95]

FDA clears a Sotera Wireless 510(k) for its continuous non-invasive blood pressure technology, a new feature for the ViSi Mobile w...

FDA Clears Integra Laminoplasty System

[ Price : $8.95]

FDA clears an Integra LifeSciences 510(k) for the Integra Laminoplasty System.

Senator Urges Probe on FDA/Pharma Pay-to-Play Controversy

[ Price : $8.95]

U.S. Senator Joe Manchin (D-WV) tells FDA commissioner Margaret Hamburg that he will seek a full congressional investigation into ...

Panel Splits on CardioMEMS Device

[ Price : $8.95]

Members of FDAs Circulatory Systems Devices Advisory Panel vote that the benefits of the CardioMEMS Champion implantable pressure ...

FDA Approves Pediatric Use for Liposorber Apheresis System

[ Price : $8.95]

FDA approves a Kaneka America Humanitarian Device Exemption for its Liposorber LA-15 System and its use in treating pediatric pati...

FDA OKs Neuros IND for Amputee Limb Pain

[ Price : $8.95]

FDA grants approval of a Neuro Medical IDE for a safety and efficacy trial of its Altius System High Frequency Nerve Block technol...

Gilead Ends Successful Idelalisib CLL Trial Early

[ Price : $8.95]

Gilead says it is ending a Phase 3 trial of idelalisib in chronic lymphocytic leukemia early because the drug showed highly statis...